* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Muscle metaboreflex increases ventricular performance in
Coronary artery disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Myocardial infarction wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Muscle metaboreflex increases ventricular performance in conscious dogs DONAL S. O’LEARY AND ROBERT A. AUGUSTYNIAK Department of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201 skeletal muscle ischemia; sympathetic nervous system; muscle afferents; arterial blood pressure; skeletal muscle blood flow WHEN OXYGEN delivery to active skeletal muscle is insufficient for ongoing metabolic demands, metabolites accumulate and stimulate group III and IV afferent neurons within the active muscle, eliciting a reflex increase in efferent sympathetic nerve activity and systemic arterial pressure (SAP) termed the muscle metaboreflex (1, 5, 7–9, 11, 16). Data from Wyss et al. (18) indicate that when this reflex is activated in conscious dogs via progressive reductions in hindlimb perfusion during treadmill exercise, a considerable fraction of the metaboreflex pressor response is due to an increase in cardiac output (CO) in addition to peripheral vasoconstriction. Other studies utilizing anesthetized animal models have shown that static muscle contraction elicits increases in the first derivative of left ventricular pressure (LV dP/dt) (14), indicating that reflexes arising from skeletal muscle afferents can induce significant increases in ventricular contractility, although with static muscle contraction it can be difficult to differentiate the relative roles of mechanosen- H220 sitive vs. metabosensitive afferents in mediating these responses. Previously, O’Leary (7) observed that in conscious dogs during dynamic exercise, the majority of the metaboreflex-induced increase in heart rate (HR) occurs via an increase in sympathetic activity to the heart. In that study, b-adrenergic blockade markedly decreased the tachycardic response to hindlimb ischemia. In addition, after b-adrenergic blockade the magnitude of the metaboreflex-induced pressor response was reduced, leading the author to conclude that the reflex tachycardia contributes importantly to the increase in arterial blood pressure. However, CO was not measured in that study. Data from Wyss et al. (18) indicate that muscle metaboreflex-induced increases in CO occur via increases in HR with little change in stroke volume (SV). Inasmuch as White et al. (17) demonstrated using conscious dogs that changes in HR over a wide range (from ,100 to 180 beats/min) per se do not elicit changes in CO due to the inverse relationship between HR and SV, muscle metaboreflex-induced tachycardia by itself likely would not elicit substantial increases in CO. Thus the data from Wyss et al. (18) indirectly allude to a reflex increase in ventricular performance; that is, muscle metaboreflex-induced increases in ventricular contractility could offset the reduction in ventricular filling time (concomitant with the increases in HR), maintaining SV essentially constant despite the tachycardia and thereby increasing CO. Alternatively, activation of the muscle metaboreflex could elicit increases in filling pressure that could maintain SV via a Frank-Starling mechanism. Thus the present study was designed to determine whether the muscle metaboreflex elicits substantial increases in ventricular performance. METHODS All experiments were performed using five conscious dogs of either gender (22–28 kg) trained to run on a motor-driven treadmill. All procedures were reviewed and approved by the Institutional Animal Care Committee and conformed to National Institutes of Health guidelines. Surgical preparation. The animals were prepared in a series of surgical sessions with at least 1 wk of recovery between surgeries and between the last surgery and the first experiment. For all procedures anesthesia was induced with Pentothal Sodium and maintained with isoflurane. Immediately before and at the completion of each surgery the animals were treated with cefazolin (500 mg iv) and then with cephalexin (30 mg/kg by mouth, 2 times/day) for at least 1 wk postoperatively. Postoperative discomfort was controlled using acepromazine (0.1 mg/kg im) and buprenorphine (0.015 mg/kg iv) whenever deemed necessary. In the first procedure, through a right thoracotomy at the fourth intercostal space, a blood flow transducer (Transonic 0363-6135/98 $5.00 Copyright r 1998 the American Physiological Society Downloaded from http://ajpheart.physiology.org/ by 10.220.32.247 on May 12, 2017 O’Leary, Donal S., and Robert A. Augustyniak. Muscle metaboreflex increases ventricular performance in conscious dogs. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H220– H224, 1998.—Ischemia of active skeletal muscle stimulates neuronal afferents within the muscle, which elicits a reflex increase in systemic arterial pressure (SAP), heart rate (HR), and cardiac output (CO) termed the muscle metaboreflex. We investigated whether activation of the muscle metaboreflex elicits increases in ventricular performance using conscious, chronically instrumented dogs trained to run on a treadmill (3.2 km/h, 0% grade). The muscle metaboreflex was activated via progressive partial vascular occlusion of the terminal aorta during control experiments and with HR maintained constant via a pacemaker connected to ventricular electrodes (225 beats/min). In control experiments, hindlimb ischemia elicited substantial increases in SAP, HR, and CO (153.9 6 4.3 mmHg, 132.4 6 4.5 beats/min, and 11.57 6 0.22 l/min, respectively; all changes P , 0.05), whereas stroke volume (SV) remained unchanged with reflex activation (control 45.9 6 2.3 vs. 46.1 6 2.4 ml, P . 0.05). During metaboreflex activation at constant HR, SV significantly increased such that the increases in CO and SAP were not significantly different from control experiments (11.77 6 0.56 l/min and 157.4 6 3.8 mmHg, P . 0.05 vs. control experiments). No significant change in central venous pressure occurred in either experiment, indicating no Frank-Starling effect on SV. We conclude that muscle metaboreflex-induced increases in ventricular contractility act to sustain SV despite decreases in ventricular filling time due to the tachycardia such that the sustained SV coupled with the tachycardia elicits substantial increases in CO that contribute importantly to the reflex increase in SAP. MUSCLE METABOREFLEX INCREASES VENTRICULAR CONTRACTILITY drugs for studies unrelated to the present investigation, respectively. An additional catheter was inserted into the right jugular vein and advanced to the atrial-caval junction to monitor central venous pressure (CVP) as an index of ventricular filling pressure in the steady state (4, 10, 15). Experimental procedures. All experiments were performed after the animals had fully recovered from surgery and were active, afebrile, and of good appetite. The animal was brought to the laboratory and allowed to roam freely for 15–30 min. The animal was then directed to the treadmill, and the blood flow transducers were connected to a flowmeter (Transonic Instruments). The FAP, SAP, and CVP catheters were connected to pressure transducers (Spectromed P-10 EZ). HR was monitored via a cardiotachometer triggered by the CO signal. SV was calculated as CO/HR. All data were sampled by a laboratory computer at 1,000 Hz, and mean values for each cardiac cycle were saved on hard disk for subsequent analysis. Fig. 1. Responses in systemic arterial pressure (SAP), heart rate (HR), cardiac output (CO) and stroke volume (SV) to progressive reductions in femoral arterial pressure (FAP) and terminal aortic blood flow (TAQ) via graded, partial vascular occlusion of the terminal aorta from 1 animal during a control experiment. Note that with metaboreflex activation marked increases in SAP, HR, and CO occurred with little change in SV. KPH, km/h; bpm, beats/min. Downloaded from http://ajpheart.physiology.org/ by 10.220.32.247 on May 12, 2017 Instruments) was placed on the ascending aorta to monitor CO and SV. Stainless steel electrodes were sutured to the apex of the left ventricle for subsequent ventricular pacing. The pericardium was reapproximated and the chest closed in layers. The wires were tunneled subcutaneously and exteriorized between the scapulae. In the second procedure, through either a midventral abdominal or retroperitoneal approach, a blood flow transducer (Transonic Instruments) and vascular occluder were placed on the terminal aorta. All side branches between the iliac arteries and the flow probe were ligated and severed. A catheter was placed in a side branch of the aorta above the flow probe and occluder to monitor SAP. The catheter, flow probe wires, and occluder tubing were tunneled subcutaneously and exteriorized between the scapulae. In the final procedure, arterial and venous catheters were implanted into small side branches of the femoral artery to monitor femoral arterial pressure (FAP) and for infusion of H221 H222 MUSCLE METABOREFLEX INCREASES VENTRICULAR CONTRACTILITY RESULTS Figure 1 shows a typical control experiment. As described previously (7–9, 11, 18), initial reductions in hindlimb perfusion during mild exercise do not elicit metaboreflex responses. However, once hindlimb perfusion is reduced below a threshold level, substantial increases in SAP, HR, and CO occur. Note that little change in SV occurred. Figure 2 shows average values of SAP, HR, CO, SV, and CVP as a function of TAQ during free-flow exercise, at metaboreflex threshold, and at the maximal level attained with the largest reductions in hindlimb perfusion during control experiments. Metaboreflex activation caused substantial and highly significant (P # 0.002) increases in SAP, HR, and CO. No significant change in SV or CVP occurred with metaboreflex activation (P 5 0.74 and 0.67, respectively). Figure 3 shows the average values of SAP, HR, CO, SV, and CVP as a function of TAQ during free-flow exercise, at metaboreflex threshold, and at the maximal level attained with the largest reductions in hindlimb perfusion when HR was maintained constant at 225 beats/min. In the absence of any change in HR, substantial increases in SAP and CO still occurred with metaboreflex activation because of the large, significant increases in SV. Fig. 2. Average levels of SAP, HR, CO, SV, and central venous pressure (CVP) during control experiments plotted as a function of TAQ during free-flow exercise (circles at right), at metaboreflex threshold (circles at middle), and at lowest imposed level of TAQ (circles at left). Once TAQ was reduced below threshold, substantial increases in SAP, HR, and CO occurred. No significant changes in either SV or CVP occurred. * P , 0.05 vs. free-flow exercise; NS, no significant change from free-flow exercise. Figure 4 shows the maximal changes in SAP, CO, SV, HR, and CVP during control experiments and during constant HR. Ventricular pacing did not significantly affect the maximal levels of SAP or CO. During control experiments, SV remained essentially constant with metaboreflex activation, whereas, at constant HR, SV increased markedly during hindlimb ischemia such that the changes in CO and SAP were not different between the control experiments vs. at constant HR. No significant change in CVP occurred in either experiment. DISCUSSION The major new finding in this study is that activation of the muscle metaboreflex in conscious dogs during dynamic exercise elicits marked increases in ventricular performance. Normally, with metaboreflex activation CO increases substantially via an increase in HR with constant SV. However, we observed that when HR was maintained constant, SV increased significantly Downloaded from http://ajpheart.physiology.org/ by 10.220.32.247 on May 12, 2017 The muscle metaboreflex was activated during mild treadmill exercise (3.2 km/h, 0% grade) as described previously (7–9, 11, 18). Briefly, the treadmill was started and after 3–5 min steady-state levels of SAP, CO, HR, SV, terminal aortic blood flow (TAQ), and FAP were achieved. Thereafter, hindlimb perfusion was progressively decreased by partially inflating the vascular occluder implanted on the abdominal aorta. Each level of reduction in hindlimb perfusion was maintained until all parameters reached steady state (3–5 min). The experiment was then repeated on a separate day, and HR was maintained constant at 225 beats/min by connecting the ventricular electrodes to a pacemaker. This level of HR was above that induced by metaboreflex activation in all dogs during control experiments. Statistical analysis. Each animal served as its own control. One-minute averages of all variables were taken during steady-state exercise and at each level of partial vascular occlusion. The data were analyzed as described by Wyss et al. (18). At this workload, initial reductions in hindlimb perfusion do not elicit metaboreflex responses. Once TAQ is reduced below a threshold level, further reductions in hindlimb perfusion elicit substantial increases in SAP, CO, and HR. Thus the relationship between hindlimb perfusion and the efferent responses (e.g., SAP, CO, HR) is ‘‘dogleg’’ in shape at this workload. Therefore, the data were approximated to two linear regressions, an initial response line wherein no substantial change in SAP, CO, and HR occurred with the initial reductions in TAQ and a pressor response line when further reductions in TAQ elicited substantial increases in the efferent responses. The intersection of these two lines is taken as the threshold for the reflex. In control experiments no change in SV occurred, and therefore these data could not be fitted by two regression lines, and the values during free-flow exercise were compared with those at the lowest level of hindlimb perfusion. The data were analyzed using repeated-measures ANOVA, and individual means were compared using modified Bonferroni tests. MUSCLE METABOREFLEX INCREASES VENTRICULAR CONTRACTILITY H223 per se, are likely more important in eliciting substantial increases in CO. With metaboreflex activation in control experiments, SV remained constant despite the reduction in ventricular filling time due to the reflex tachycardia. White et al. (17) demonstrated using conscious dogs that changes in ventricular rate within the range observed with metaboreflex activation in this model do not elicit any significant change in CO due to the reduction in SV. As HR increases, SV decreases proportionately, presumably due to the reduction in ventricular filling time, thereby causing the product of SV and HR (e.g., CO) to remain unchanged. Thus our Downloaded from http://ajpheart.physiology.org/ by 10.220.32.247 on May 12, 2017 Fig. 3. Average levels of SAP, HR, CO, SV, and CVP during constant ventricular pacing plotted as a function of TAQ during free-flow exercise (circles at right), at metaboreflex threshold (circles in middle), and at lowest imposed level of TAQ (circles at left). Note that at constant HR, metaboreflex activation elicited a substantial increase in SV such that the increases in SAP and CO were similar to control experiments. * P , 0.05 vs. free-flow exercise; NS, no significant change from free flow exercise. with metaboreflex activation such that the increases in CO and SAP were indistinguishable from control experiments. Thus, with activation of the muscle metaboreflex in the normal animal, despite decreases in ventricular filling time due to the reflex tachycardia, SV remains unchanged due to the increase in ventricular performance, thereby allowing CO to increase substantially and contribute importantly to the pressor response. Previously, O’Leary (7) observed that after b-adrenergic blockade both the reflex tachycardia and pressor responses to metaboreflex activation in conscious dogs were significantly attenuated, leading to the conclusion that the HR component of the reflex contributed importantly to the pressor response. However, CO was not measured in that study. Because b-adrenergic blockade will affect both chronotropic and inotropic function, we utilized ventricular pacing to investigate whether metaboreflex activation elicits increases in ventricular performance. The present investigation indicates that increases in ventricular contractility, rather than HR Fig. 4. Average maximal changes in SAP, CO, SV, HR, and CVP in response to metaboreflex activation during control experiments and during constant HR. Note that maximal increases in SAP and CO were not significantly different between control experiments and at constant HR. * P , 0.05, change significantly different from constant HR; NS, no significant difference. H224 MUSCLE METABOREFLEX INCREASES VENTRICULAR CONTRACTILITY The authors thank Sue Harris and Susanne LaPrad for expert technical assistance. This study was supported by National Heart, Lung, and Blood Institute Grants HL-02844 and HL-55473. Address for reprint requests: D. S. O’Leary, Dept. of Physiology, Wayne State Univ. School of Medicine, 540 E. Canfield Ave., Detroit, MI 48201. Received 22 December 1997; accepted in final form 23 March 1998. REFERENCES 1. Collins, H. L., and S. E. DiCarlo. Cardiac afferents attenuate the muscle metaboreflex in the rat. J. Appl. Physiol. 75: 114–120, 1993. 2. Kaufman, M. P., J. C. Longhurst, K. J. Rybicki, J. H. Wallach, and J. H. Mitchell. Effects of static muscular contraction on impulse activity of groups III and IV afferents in cats. J. Appl. Physiol. 55: 105–112, 1983. 3. Kaufman, M. P., and K. J. Rybicki. Discharge properties of group III and IV muscle afferents: their responses to mechanical and metabolic stimuli. Circ. Res. 61 Suppl. I: I-60–I-65, 1987. 4. Luchsinger, P. C., H. W. Seipp, Jr., and D. J. Patel. Relationship of pulmonary artery-wedge pressure to left atrial pressure in man. Circ. Res. 11: 315–318, 1962. 5. Mark, A. L., R. G. Victor, C. Nerhed, and B. G. Wallin. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ. Res. 57: 461–469, 1985. 6. Nobrega, A. C. L., J. W. Williamson, J. A. Garcia, and J. H. Mitchell. Mechanisms for increasing stroke volume during static exercise with fixed heart rate in humans. J. Appl. Physiol. 83: 712–717, 1997. 7. O’Leary, D. S. Autonomic mechanisms of muscle metaboreflex control of heart rate. J. Appl. Physiol. 74: 1748–1754, 1993. 8. O’Leary, D. S., N. F. Rossi, and P. C. Churchill. Muscle metaboreflex control of vasopressin and renin release. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1422–H1427, 1993. 9. O’Leary, D. S., and D. D. Sheriff. Is the muscle metaboreflex important in control of blood flow to ischemic active skeletal muscle? Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H980– H986, 1995. 10. Reeves, J. T., B. M. Groves, A. Cymerman, J. R. Sutton, P. D. Wagner, D. Turkevich, and C. S. Houston. Operation Everest II: cardiac filling pressures during cycle exercise at sea level. Respir. Physiol. 80: 147–154, 1990. 11. Sheriff, D. D., D. S. O’Leary, A. M. Scher, and L. B. Rowell. Baroreflex attenuates pressor response to graded muscle ischemia in exercising dogs. Am. J. Physiol. 258 (Heart Circ. Physiol. 27): H305–H310, 1990. 12. Stebbins, C. L. Reflex cardiovascular response to exercise is modulated by circulating vasopressin. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): R1104–R1109, 1992. 13. Stebbins, C. L., B. Brown, D. Levin, and J. C. Longhurst. Reflex effect of skeletal muscle mechanoreceptor stimulation on the cardiovascular system. J. Appl. Physiol. 65: 1539–1547, 1988. 14. Stebbins, C. L., A. Ortiz-Acevedo, and J. M. Hill. Spinal vasopressin modulates the reflex cardiovascular response to static contraction. J. Appl. Physiol. 72: 731–738, 1992. 15. Verel, D., and N. H. Stentiford. Comparision of left atrial pressure and wedge pulmonary capillary pressure: pressure gradients between left atrium and left ventricle. Br. Heart J. 32: 99–102, 1970. 16. Victor, R. G., D. R. Seals, and A. L. Mark. Differential control of heart rate and sympathetic nerve activity during dynamic exercise. J. Clin. Invest. 79: 508–516, 1987. 17. White, S., C. B. Higgins, S. F. Vatner, D. Franklin, E. Braunwald, and T. Patrick. Effects of altering ventricular rate on blood flow distribution in conscious dogs. Am. J. Physiol. 221 : 1402–1407, 1971. 18. Wyss, C. R., J. L. Ardell, A. M. Scher, and L. B. Rowell. Cardiovascular responses to graded reductions in hindlimb perfusion in exercising dogs. Am. J. Physiol 245 (Heart Circ. Physiol. 14): H481–H486, 1983. Downloaded from http://ajpheart.physiology.org/ by 10.220.32.247 on May 12, 2017 results from the control experiments indirectly indicate a significant role for increases in ventricular contractility with metaboreflex activation. In the control experiments SV remained unchanged despite significant increases in HR (and thus reductions in ventricular filling time), thereby allowing CO to increase markedly. Furthermore, when HR was maintained constant, SV increased significantly during metaboreflex activation such that the increases in CO (and SAP) were virtually the same as in control experiments (Fig. 4). Because no significant change in CVP occurred in either control experiments or during constant HR, the rise in SV during metaboreflex activation at constant HR is not likely to be a consequence of the Frank-Starling effect but likely reflects the effects of increases in sympathetic activity to the ventricular myocardium eliciting increases in ventricular contractility. Thus, in the previous study by O’Leary (7) in which b-adrenergic blockade attenuated both the tachycardia and pressor responses to muscle metaboreflex activation, it is likely that the reflex increases in ventricular contractility were attenuated (or abolished) by the b-adrenergic blockade, and thus the reduced pressor responses were a consequence of attenuated increases in CO. In support of the concept that activation of muscle afferents can elicit changes in ventricular contractility, Stebbins et al. (12, 14) demonstrated using anesthetized cats that electrically induced static muscle contraction causes significant increases in LV dP/dt. In addition, recently Nobrega et al. (6) observed in humans with atrioventricular block that SV increased significantly during static knee extension when HR was maintained constant at the peak level observed in control experiments when HR was allowed to increase (via a dual-chamber sensing and pacing pacemaker). In that experiment, at constant high HR, the increase in SV during static contraction was accomplished via a decrease in end-systolic volume with no change in end-diastolic volume, indicating that the rise in SV and CO was mediated via an increase in ventricular contractility. However, because static muscle contraction activates both mechano- and metabosensitive afferents (2, 3) and that activation of mechanosensitive afferents also elicits increases in ventricular contractility (13), to what extent the ventricular contractility responses observed with static muscle contraction are attributable to the muscle metaboreflex vs. mechanoreflex is unclear. In summary, activation of the muscle metaboreflex during dynamic exercise elicits increases in ventricular performance such that SV remains unchanged despite large increases in HR. The combination of constant SV with the reflex tachycardia results in marked increases in CO that, combined with peripheral vasoconstriction, cause substantial increases in arterial blood pressure.